SCHEMBL7990902

SCHEMBL7990902

CC(=O)[C@H]1[C@@H](C)C[C@H]2[C@@H]3CC=C4CC(O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.74
NR3C1 P04150 1/20 0.74
MAPK1 P28482 1/20 0.74
SMN1; SMN2 Q16637 1/20 0.74
SIGMAR1 Q99720 1/20 0.74
SHBG P04278 4/20 0.67
G6PD P11413 4/20 0.67
LMNA P02545 3/20 0.67
SERPINA6 P08185 3/20 0.67
DPP4 P27487 1/20 0.65
CYP19A1 P11511 1/20 0.62
ESR1 P03372 1/20 0.61
AR P10275 1/20 0.61
ESR2 Q92731 1/20 0.61
CYP17A1 P05093 7/20 0.60
MEN1 O00255 1/20 0.58
GUSB P08236 1/20 0.58
CYP3A4 P08684 1/20 0.58
PMP22 Q01453 1/20 0.58
KMT2A Q03164 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3995417 1.00 ALDH1A1 (0.74) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL6331608 1.00 ALDH1A1 (0.74) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL3995420 1.00 ALDH1A1 (0.74) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL28639440 1.00 ALDH1A1 (0.74) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL6331607 1.00 ALDH1A1 (0.74) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
Ethylene SCHEMBL11877718 0.98 ALDH1A1 (0.71) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL6336489 0.90 ALDH1A1 (0.76) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL6336492 0.90 ALDH1A1 (0.76) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL21594801 0.90 ALDH1A1 (0.76) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1
SCHEMBL15173566 0.90 ALDH1A1 (0.76) ALDH1A1NR3C1MAPK1SMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274118-B1 INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE NORDION INTERNATIONAL INC. (CA) 2001-08-14 US disclosed
WO-1995002424-A1 LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN NORDION INTERNATIONAL INC. (CA) 1995-01-26 WO disclosed